comparemela.com

Latest Breaking News On - ரிக் பால்ஸ் - Page 1 : comparemela.com

DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for . Autore : DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference (Di giovedì 29 luglio 2021) (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the Rick Pauls, President and . Leggi su 01net DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference Business Wire Business Wire - 29 Luglio 2021 MINNEAPOLIS - - (BUSINESS WIRE) - - DiaMedica . DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical - stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the .

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

MINNEAPOLIS (BUSINESS WIRE) Jul 15, 2021 DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Company’s Board of Directors. Amy Burroughs, President and CEO of Cleave Therapeutics, brings over 20 years of experience in business and commercial development, strategy and leadership in the pharmaceutical industry. Dr. Charles Semba, Chief Medical Officer of Eluminex Biosciences, has over 20 years of drug-development experience in high growth public and private therapeutics companies and serves on the faculty of Vascular/Interventional Radiology at Stanford University.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.